Michael C Chen

Title: Michael C Chen: Innovator in Recombinant DNA Technology

Introduction

Michael C Chen is a notable inventor based in Painted Post, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant deoxyribonucleic acid (DNA) technologies. His work has implications for medical advancements and therapeutic applications.

Latest Patents

Michael C Chen holds a patent for a recombinant deoxyribonucleic acid that codes for plasminogen activator. This invention provides a DNA segment related to a human plasminogen activator gene. The segment is inserted into a plasmid vector, which can then be incorporated into a bacterium or other microorganisms. The cultured bacterium can produce a plasminogen activator protein that exhibits properties similar to human urokinase. This innovation has the potential to enhance medical treatments involving blood clot management.

Career Highlights

Michael C Chen is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to contribute to groundbreaking research and development in biotechnology. With a focus on recombinant DNA technology, he has played a crucial role in advancing therapeutic solutions.

Collaborations

Michael has collaborated with esteemed colleagues such as Shaw-guang Lee and Paul P Hung. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Michael C Chen is a distinguished inventor whose work in recombinant DNA technology has the potential to impact medical science significantly. His contributions, particularly in the development of plasminogen activator, highlight the importance of innovation in healthcare.